JP5468900B2 - 置換されたアニリン誘導体 - Google Patents

置換されたアニリン誘導体 Download PDF

Info

Publication number
JP5468900B2
JP5468900B2 JP2009521335A JP2009521335A JP5468900B2 JP 5468900 B2 JP5468900 B2 JP 5468900B2 JP 2009521335 A JP2009521335 A JP 2009521335A JP 2009521335 A JP2009521335 A JP 2009521335A JP 5468900 B2 JP5468900 B2 JP 5468900B2
Authority
JP
Japan
Prior art keywords
alkyl
compound
hydrogen
group
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009521335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009544676A5 (cg-RX-API-DMAC7.html
JP2009544676A (ja
Inventor
アンドリュー・デイビッド・カー
ジュディ・シャーロット・ノイス
マイケル・グレン・オーチャード
デイビッド・ウィリアム・ポーター
Original Assignee
ユセベ ファルマ ソシエテ アノニム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0614677A external-priority patent/GB0614677D0/en
Priority claimed from GB0614678A external-priority patent/GB0614678D0/en
Priority claimed from GB0704645A external-priority patent/GB0704645D0/en
Priority claimed from GB0704648A external-priority patent/GB0704648D0/en
Application filed by ユセベ ファルマ ソシエテ アノニム filed Critical ユセベ ファルマ ソシエテ アノニム
Publication of JP2009544676A publication Critical patent/JP2009544676A/ja
Publication of JP2009544676A5 publication Critical patent/JP2009544676A5/ja
Application granted granted Critical
Publication of JP5468900B2 publication Critical patent/JP5468900B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/06—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2009521335A 2006-07-24 2007-07-24 置換されたアニリン誘導体 Expired - Fee Related JP5468900B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0614677A GB0614677D0 (en) 2006-07-24 2006-07-24 Substituted Aniline Derivatives
GB0614678A GB0614678D0 (en) 2006-07-24 2006-07-24 Substituted aniline derivatives
GB0614678.1 2006-07-24
GB0614677.3 2006-07-24
GB0704645.1 2007-03-09
GB0704645A GB0704645D0 (en) 2007-03-09 2007-03-09 Substituted aniline derivatives
GB0704648A GB0704648D0 (en) 2007-03-09 2007-03-09 Substituted aniline derivatives
GB0704648.5 2007-03-09
PCT/GB2007/002815 WO2008012524A1 (en) 2006-07-24 2007-07-24 Substituted aniline derivatives

Publications (3)

Publication Number Publication Date
JP2009544676A JP2009544676A (ja) 2009-12-17
JP2009544676A5 JP2009544676A5 (cg-RX-API-DMAC7.html) 2013-07-04
JP5468900B2 true JP5468900B2 (ja) 2014-04-09

Family

ID=38484243

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009521335A Expired - Fee Related JP5468900B2 (ja) 2006-07-24 2007-07-24 置換されたアニリン誘導体

Country Status (6)

Country Link
US (3) US7678785B2 (cg-RX-API-DMAC7.html)
EP (1) EP2046739B1 (cg-RX-API-DMAC7.html)
JP (1) JP5468900B2 (cg-RX-API-DMAC7.html)
AU (1) AU2007279092B2 (cg-RX-API-DMAC7.html)
CA (1) CA2658913C (cg-RX-API-DMAC7.html)
WO (1) WO2008012524A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008012524A1 (en) 2006-07-24 2008-01-31 Ucb Pharma S.A. Substituted aniline derivatives
MX2009004619A (es) 2006-10-31 2009-05-15 Cadila Healthcare Ltd Agonistas selectivos del receptor tiroideo (tr) beta 1.
TWI386204B (zh) 2008-04-10 2013-02-21 Mitsubishi Tanabe Pharma Corp 高半胱胺酸合成酶抑制劑
KR20110025915A (ko) * 2008-06-16 2011-03-14 에프. 호프만-라 로슈 아게 오렉시닌 수용체 길항제로서 헤테로방향족 모노아마이드
WO2011043480A1 (ja) * 2009-10-09 2011-04-14 田辺三菱製薬株式会社 ホモシステイン合成酵素阻害薬
MX2013007189A (es) * 2010-12-21 2013-07-12 Nestec Sa Metodos y composiciones adecuados para manejar glucosa en sangre en animales.
RU2541532C2 (ru) * 2012-10-16 2015-02-20 Федеральное Государственное Бюджетное Учреждение Науки Институт Нефтехимии И Катализа Ран Ди-[4-(диметиламинометилсульфанил)-фениловый] эфир щавелевокислый - водорастворимое средство для борьбы с почвенной и поверхностно-семенной инфекцией
CN106563929B (zh) 2015-10-08 2019-09-17 利宝地工程有限公司 修复和制造涡轮发动机部件的方法及涡轮发动机部件
WO2018048882A1 (en) 2016-09-06 2018-03-15 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
CN108172553A (zh) * 2018-01-17 2018-06-15 杭州暖芯迦电子科技有限公司 一种视网膜假体植入芯片的封装结构及其封装方法
CN116947678B (zh) * 2023-07-24 2025-07-08 河南大学 一类氮原子双取代芳香环类小分子有机化合物及其衍生物及其在制备抗菌药物中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2676188A (en) * 1950-12-16 1954-04-20 American Home Prod Acylated glycinamides
US4205168A (en) * 1973-09-24 1980-05-27 Chevron Research Company N-Carbamylalkyl-2,6-dialkyl-α-haloacetanilides
US3944607A (en) * 1974-10-17 1976-03-16 Chevron Research Company Herbicidal N-(N'-alkynylcarbamylmethyl)-2,6-dialkyl-α-haloacetanilides
JPS51125741A (en) * 1974-10-17 1976-11-02 Chevron Res Weed killer
LU78804A1 (de) * 1977-12-30 1979-07-20 Byk Gulden Lomberg Chem Fab N-substituierte w-aminoalkanoyl-w-aminoalkansaeuren,ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DE3114351A1 (de) * 1981-04-09 1982-11-04 Hoechst Ag, 6000 Frankfurt "oxindol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung"
JPS58154567A (ja) * 1982-03-09 1983-09-14 Teikoku Chem Ind Corp Ltd チオフエノ−ル誘導体及びその製造方法
US4736066A (en) * 1982-07-19 1988-04-05 E. R. Squibb & Sons, Inc. Intermediate for substituted peptide compounds
JPH01211560A (ja) * 1988-02-18 1989-08-24 Sagami Chem Res Center β−ラクタム誘導体の製造方法
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US6350761B1 (en) * 1999-07-30 2002-02-26 Berlex Laboratories, Inc. Benzenamine derivatives as anti-coagulants
CN1474803B (zh) * 2000-09-14 2012-11-21 田边三菱制药株式会社 酰胺衍生物及其制备药物的用途
RU2247716C2 (ru) 2003-03-27 2005-03-10 Российский химико-технологический университет им. Д.И. Менделеева (РХТУ) Замещенные метил-n-амидооксамоил-n-фенил-d, l-аланинаты и их способы получения
EP1669348A4 (en) * 2003-09-30 2009-03-11 Eisai R&D Man Co Ltd NEW ANTIPILIC AGENT CONTAINING A HETEROCYCLIC COMPOUND
JP2005202314A (ja) * 2004-01-19 2005-07-28 Fuji Photo Film Co Ltd 重合性組成物及びそれを用いた画像形成材料
US20070191395A1 (en) * 2004-02-16 2007-08-16 Katsuhiro Kawakami Heterocyclic compounds having antifungal activity
WO2006012441A1 (en) * 2004-07-23 2006-02-02 Susan Marie Royalty Peptidase inhibitors
WO2006106711A1 (ja) * 2005-03-30 2006-10-12 Eisai R & D Management Co., Ltd. ピリジン誘導体を含有する抗真菌剤
EP1932837A4 (en) * 2005-08-17 2011-05-25 Daiichi Sankyo Co Ltd HETEROCYCLIC BICYCLOUS BINDING WITH ANTIPILY EFFECT
WO2008012524A1 (en) 2006-07-24 2008-01-31 Ucb Pharma S.A. Substituted aniline derivatives

Also Published As

Publication number Publication date
EP2046739B1 (en) 2015-08-26
CA2658913C (en) 2015-07-21
WO2008012524A1 (en) 2008-01-31
US20120029188A1 (en) 2012-02-02
US20110014271A1 (en) 2011-01-20
AU2007279092B2 (en) 2012-12-13
JP2009544676A (ja) 2009-12-17
EP2046739A1 (en) 2009-04-15
US8071582B2 (en) 2011-12-06
US8624022B2 (en) 2014-01-07
CA2658913A1 (en) 2008-01-31
AU2007279092A1 (en) 2008-01-31
US7678785B2 (en) 2010-03-16
US20080045497A1 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
JP5468900B2 (ja) 置換されたアニリン誘導体
EP3233863B1 (en) Fused ring heteroaryl compounds and their use as trk inhibitors
JP2022513959A (ja) 大環状化合物及び疾患の処置におけるそれらの使用
TWI655185B (zh) 用於治療疾病之葡萄糖腦醯胺合成酶抑制劑
US20240116870A1 (en) N,n-dimethyltryptamine and related psychedelics and uses thereof
US20250074890A1 (en) Cyanopyridine and cyanopyrimidine bcl6 degraders
US11884627B2 (en) Compounds and compositions for treating conditions associated with LPA receptor activity
US11292801B2 (en) Calpain modulators and therapeutic uses thereof
US12390449B2 (en) Substituted 2-aminobenzimidazoles analogs as antibiofilm agents
US20250387373A1 (en) Substituted 2-aminobenzimidazoles analogs as antibiofilm agents
RU2804139C2 (ru) Макроциклические соединения и их применение в лечении заболевания
JP2020504127A (ja) モルフィナン誘導体と自己免疫、炎症または感染に関連する障害の治療に用いるモルフィナン誘導体含有組成物
JP2009517483A (ja) 一酸化窒素シンターゼの二量化の抑制剤としてのイミダゾール誘導体
CA3039586A1 (en) 4,4a,5,7-tetrahydro-3h-furo[3,4-b]pyridinyl compounds

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100722

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130205

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130502

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130513

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20130515

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140121

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140130

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees